MarkWide Research

Sale!

Femtech Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Femtech Market size valued at over USD 22.5 billion in 2020 and is expected to grow at a CAGR of 16.2% from 2021 to 2027. Advancements in service development technologies has improved its potential in basic research and clinical applications. Currently, number of femtech services are available with numerous applications. With effectiveness in disease diagnosis and treatment, the market will witness lucrative growth during the forecast timeframe.

Initiatives taken by government for awareness of women health as well as advanced technological solutions for precise treatment will impel the market expansion. Major healthcare players are emphasizing on creating product pipeline using digital technology. Also, growing companies are majorly investing in R&D to develop innovative products for providing better solutions to women.

Rise in burden of lifestyle diseases and access to remote areas regarding women health will foster the market progression

Femtech market has experienced significant positive impact of COVID-19 as several lifestyle diseases affected women health. During pandemic, women faced increasing concern of health conditions such as reproductive disease due to changed lifestyle habits, mental health, high risk of developing metabolic syndrome and other chronic diseases. In pregnancy, mainly miscarriages, stillbirths, and birth complications cases arise that leads into anxiety, depression and hormonal imbalance.
Thus, with growing health concerns coupled with restrictive guidelines during the pandemic, industry leaders developed innovative software, services and products with use of digital technology to reach in remote areas across the world. The new generation services provide remote healthcare services to healthcare professionals in hospitals, fertility clinics, diagnostic centers as well as to the patients remotely.

Effectivity of advanced products in women health will stimulate product adoption in women healthcare segment

The products segment dominated more than 50% of the femtech market revenue share in 2020. Demand for products owing to high prevalence of chronic and infectious diseases among women for precise diagnostics and treatment spurs the industry growth. Advancements in women health products such as fitness trackers, wearables, exercise products and women hygiene products among others will influence the industry expansion.

Innovation through smart medical products is driving the market value. The companies are mainly focusing on development of ground-breaking solutions for female health and wellness. The products assist women health during pregnancy by using technological solutions. Competitive leaders investing in the technology are offering diverse products for major applications.

Increasing demand for reproductive health will strengthen the market demand

Reproductive health segment captured 24.5% of the femtech market share in 2020 led by the growing awareness regarding reproductive health in majority economies. The services and advanced software enabled-products assist in treatment with several conditions such as sexual and gynaecological health, infections and numerous diseases
The industry participants are adopting developmental activities, leading to expansion of offerings and product pipeline for reproductive health of female. Moreover, booming number of new companies that are entering the market are offering various products to manage reproductive health. Along with growing accessibility to feminine products, female population in emerging areas is adopting products for maintaining reproductive health with greater awareness, that will eventually propel the segment growth.

Growing patient inflow prone to several diseases will simulate growth potential of diagnostic centers segment

Femtech market demand from diagnostic centers is projected to showcase 16% growth rate through 2027. Diagnostic centers offer various specialty diagnosis options for chronic and infectious diseases.
Advent of digital health, especially telehealth solutions, has accelerated patient care process. This has allowed reduction in patient visits, even in the pandemic. Telehealth solutions assist by supporting the patient diagnosis and consultations remotely.

Presence of leading companies catering to attractive product demand will continue to strengthen the market growth in the European region

Europe femtech market held over 28% of the revenue share in 2020 on account of the presence of leading industry players with strong product demand in the market. Expansion of manufacturing capacities will further boost product availability and sales. Additionally, increasing number of start-ups in the region will augment the regional growth in the coming years.

Product innovations and partnerships to widen offerings are assisting the firms in business expansion

The global femtech market consists of several leaders including HeraMED, Totohealth, Sustain Natural, iSona Health, Minvera, Athena Feminine Technologies, Sera Prognostics, Nuvo, Elvie, Univfy, and Prelude among others. These firms are undertaking several expansion and growth strategies to increase their market presence.

Some of the recent industry developments:

  • In September 2020, HeraMED announced Partnership with eCare21, a leading virtual care platform to integrate its heartCARE & heartBEAT products with eCare21 platform. This has enhanced product portfolio and development capabilities of the firm.
  • In August 2019, Grove collaborative acquired Sustain Natural, a leading company in natural sexual wellness products. This strategy fortified the firms product portfolio and market position.

The femtech market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Type

  • Products
  • Software
  • Services

Market, By Application

  • Reproductive health
  • Pregnancy & nursing care
  • Pelvic & uterine healthcare
  • General healthcare & wellness
  • Others

Market, By End-use

  • Direct to customer
  • Hospitals
  • Fertility clinics
  • Surgical centers
  • Diagnostic centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    MEA

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Femtech industry 3600 synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Application trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Femtech Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Usage of digital technology to manage women health in developed countries

3.3.1.2    Improving access to women care in remote areas

3.3.1.3    Growing awareness regarding women health and wellness in developing countries

3.3.1.4    Increasing burden of chronic and infectious diseases among females

3.3.1.5    Growing investment in femtech industry

3.3.2    Industry pitfalls & challenges

3.3.2.1    Lack of awareness about femtech products and applications in some developing regions

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By application

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Start-up scenario

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.9    PESTEL analysis

Chapter 4   Femtech Market, By Type

4.1    Key segment trends

4.2    Products

4.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Software

4.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.4    Services

4.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 5   Femtech Market, By Application

5.1    Key segment trends

5.2    Reproductive health

5.2.1    Market size, by region, 2016 – 2027 (USD Million)

5.3    Pregnancy & nursing care

5.3.1    Market size, by region, 2016 – 2027 (USD Million)

5.4    Pelvic & uterine healthcare

5.4.1    Market size, by region, 2016 – 2027 (USD Million)

5.5    General healthcare & wellness

5.5.1    Market size, by region, 2016 – 2027 (USD Million)

5.6    Others

5.6.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 6   Femtech Market, By End-use

6.1    Key segment trends

6.2    Direct-to-consumer

6.2.1    Market size, by region, 2016 – 2027 (USD Million)

6.3    Hospitals

6.3.1    Market size, by region, 2016 – 2027 (USD Million)

6.4    Fertility clinics

6.4.1    Market size, by region, 2016 – 2027 (USD Million)

6.5    Surgical centers

6.5.1    Market size, by region, 2016 – 2027 (USD Million)

6.6    Diagnostic centers

6.6.1    Market size, by region, 2016 – 2027 (USD Million)

6.7    Others

6.7.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 7   Femtech Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2016 – 2027 (USD Million)

7.2.2    Market size, by type, 2016 – 2027 (USD Million)

7.2.3    Market size, by application, 2016 – 2027 (USD Million)

7.2.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by type, 2016 – 2027 (USD Million)

7.2.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.2.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by type, 2016 – 2027 (USD Million)

7.2.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.2.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2016 – 2027 (USD Million)

7.3.2    Market size, by type, 2016 – 2027 (USD Million)

7.3.3    Market size, by application, 2016 – 2027 (USD Million)

7.3.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.7    France

7.3.7.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.8    Italy

7.3.8.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.8.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.9    Spain

7.3.9.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.9.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.10    Russia

7.3.10.1    Market size, by type, 2016 – 2027 (USD Million)

7.3.10.2    Market size, by application, 2016 – 2027 (USD Million)

7.3.10.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2016 – 2027 (USD Million)

7.4.2    Market size, by type, 2016 – 2027 (USD Million)

7.4.3    Market size, by application, 2016 – 2027 (USD Million)

7.4.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.5    Japan

7.4.5.1    Market size, by type, 2016 – 2027 (USD Million)

7.4.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.6    China

7.4.6.1    Market size, by type, 2016 – 2027 (USD Million)

7.4.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.7    India

7.4.7.1    Market size, by type, 2016 – 2027 (USD Million)

7.4.7.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.8    Australia

7.4.8.1    Market size, by type, 2016 – 2027 (USD Million)

7.4.8.2    Market size, by application, 2016 – 2027 (USD Million)

7.4.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2016 – 2027 (USD Million)

7.5.2    Market size, by type, 2016 – 2027 (USD Million)

7.5.3    Market size, by application, 2016 – 2027 (USD Million)

7.5.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size, by type, 2016 – 2027 (USD Million)

7.5.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.5.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size, by type, 2016 – 2027 (USD Million)

7.5.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.5.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6    MEA

7.6.1    Market size, by country, 2016 – 2027 (USD Million)

7.6.2    Market size, by type, 2016 – 2027 (USD Million)

7.6.3    Market size, by application, 2016 – 2027 (USD Million)

7.6.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.5    Saudi Arabia

7.6.5.1    Market size, by type, 2016 – 2027 (USD Million)

7.6.5.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.6    South Africa

7.6.6.1    Market size, by type, 2016 – 2027 (USD Million)

7.6.6.2    Market size, by application, 2016 – 2027 (USD Million)

7.6.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    Athena Feminine Technologies

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    BioWink GmbH

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Conceivable, Inc.

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Elvie

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    HeraMED

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    iSono Health

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Minerva Surgical

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Nuvo Cares

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Prelude

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Sera Prognostics

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Sustain Natural

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Univfy

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    Totohealth

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

Data Tables

TABLE 1.    Femtech market, 2016 – 2027 (USD Million)

TABLE 2.    Femtech market, by type, 2016 – 2027 (USD Million)

TABLE 3.    Femtech market, by application, 2016 – 2027 (USD Million)

TABLE 4.    Femtech market, by end-use, 2016 – 2027 (USD Million)

TABLE 5.    Femtech market, by region, 2016 – 2027 (USD Million)

TABLE 6.    Industry impact forces

TABLE 7.    Products market size, by region, 2016 – 2027 (USD Million)

TABLE 8.    Software market size, by region, 2016 – 2027 (USD Million)

TABLE 9.    Services market size, by region, 2016 – 2027 (USD Million)

TABLE 10.    Reproductive health market size, by region, 2016 – 2027 (USD Million)

TABLE 11.    Pregnancy & nursing care market size, by region, 2016 – 2027 (USD Million)

TABLE 12.    Pelvic & uterine healthcare market size, by region, 2016 – 2027 (USD Million)

TABLE 13.    General healthcare & wellness market size, by region, 2016 – 2027 (USD Million)

TABLE 14.    Others market size, by region, 2016 – 2027 (USD Million)

TABLE 15.    Direct-to-consumer market size, by region, 2016 – 2027 (USD Million)

TABLE 16.    Hospitals market size, by region, 2016 – 2027 (USD Million)

TABLE 17.    Fertility clinics market size, by region, 2016 – 2027 (USD Million)

TABLE 18.    Surgical centers market size, by region, 2016 – 2027 (USD Million)

TABLE 19.    Diagnostic centers market size, by region, 2016 – 2027 (USD Million)

TABLE 20.    Others market size, by region, 2016 – 2027 (USD Million)

TABLE 21.    North America femtech market size, by country, 2016 – 2027 (USD Million)

TABLE 22.    North America femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 23.    North America femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 24.    North America femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 25.    U.S. femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 26.    U.S. femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 27.    U.S. femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 28.    Canada femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 29.    Canada femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 30.    Canada femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 31.    Europe femtech market size, by country, 2016 – 2027 (USD Million)

TABLE 32.    Europe femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 33.    Europe femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 34.    Europe femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 35.    Germany femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 36.    Germany femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 37.    Germany femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 38.    UK femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 39.    UK femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 40.    UK femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 41.    France femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 42.    France femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 43.    France femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 44.    Italy femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 45.    Italy femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 46.    Italy femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 47.    Spain femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 48.    Spain femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 49.    Spain femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 50.    Russia femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 51.    Russia femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 52.    Russia femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 53.    Asia Pacific femtech market size, by country, 2016 – 2027 (USD Million)

TABLE 54.    Asia Pacific femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 55.    Asia Pacific femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 56.    Asia Pacific femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 57.    China femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 58.    China femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 59.    China femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 60.    Japan femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 61.    Japan femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 62.    Japan femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 63.    India femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 64.    India femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 65.    India femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 66.    Australia femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 67.    Australia femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 68.    Australia femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 69.    Latin America femtech market size, by country, 2016 – 2027 (USD Million)

TABLE 70.    Latin America femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 71.    Latin America femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 72.    Latin America femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 73.    Brazil femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 74.    Brazil femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 75.    Brazil femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 76.    Mexico femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 77.    Mexico femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 78.    Mexico femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 79.    MEA femtech market size, by country, 2016 – 2027 (USD Million)

TABLE 80.    MEA femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 81.    MEA femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 82.    MEA femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 83.    Saudi Arabia femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 84.    Saudi Arabia femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 85.    Saudi Arabia femtech market size, by end-use, 2016 – 2027 (USD Million)

TABLE 86.    South Africa femtech market size, by type, 2016 – 2027 (USD Million)

TABLE 87.    South Africa femtech market size, by application, 2016 – 2027 (USD Million)

TABLE 88.    South Africa femtech market size, by end-use, 2016 – 2027 (USD Million)

Charts & Figures

FIG 1.     Industry segmentation

FIG 2.     Growth potential analysis, by type

FIG 3.     Growth potential analysis, by application

FIG 4.     Growth potential analysis, by end-use

FIG 5.     Porter’s analysis

FIG 6.     PESTEL analysis

FIG 7.     Key segment trends, by type

FIG 8.     Key segment trends, by application

FIG 9.     Key segment trends, by end-use

FIG 10.  Key regional trends

FIG 11.  Competitive dashboard, 2020

Market, By Type

  • Products
  • Software
  • Services

Market, By Application

  • Reproductive health
  • Pregnancy & nursing care
  • Pelvic & uterine healthcare
  • General healthcare & wellness
  • Others

Market, By End-use

  • Direct to customer
  • Hospitals
  • Fertility clinics
  • Surgical centers
  • Diagnostic centers
  • Others

HeraMED, Totohealth, Sustain Natural, iSona Health, Minvera, Athena Feminine Technologies, Sera Prognostics, Nuvo, Elvie, Univfy, and Prelude among others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF